Country Meeting:

DAY 1 – Thursday, November 17th 2016

SESSION 1: WECLOMING AND REVIEW OF THE MEETING OBJECTIVES   
Chairs: Robb Butler & Palle Valentiner-Branth

• Welcome by Director of the Division of Health Emergencies and Communicable Diseases (DEC)
  Nedret Emiroglu, WHO EURO

• Welcome and review of the meeting objectives and programme
  Alex Vorsters, University of Antwerp

SESSION 2: The Danish Health Care System

• The Danish health care system and overview of all vaccinations programs 
  Camilla Rosengaard Villumsen, Ministry of Health (Denmark)

SESSION 3: Epidemiology, burden of disease and surveillance 

• Epidemiology of HPV and burden of HPV-related neoplasia in Denmark
  Susanne Krüger Kjær, Ringshospitalet & Danish Cancer Society (Denmark)

• HPV surveillance
  Christian Munk, Danish Cancer Society (Denmark)

• Monitoring adverse events following immunization with HPV-vaccines in Denmark
  Line Michan, Danish Medicines Agency (Denmark)

• Questions & discussion

SESSION 4: PREVENTION AND CONTROL OF HPV IN DENMARK 
Chairs: Kate Cuschieri & Kåre Mølbak

• HPV vaccination programmes in Denmark
  Palle Valentiner-Branth, Statens Serum Institut (Denmark)

• Cervical cancer screening programmes in Denmark
  Elsebeth Lynge, University of Copenhagen (Denmark)

• Home sampling for hrHPV testing in Central Denmark Region 
  Berit Andersen, Regionshospitalet Randers (Denmark)

• Questions & discussion

Chairs: Susan Wang & Scott Wittet

• Cervical cancer treatment and late effects 
  Pernille Tine Jensen, Odense University Hospital (Denmark)

SESSION 5: ACHIEVEMENTS AND CHALLENGES IN DENMARK AND LESSONS LEARNT

• The case of POTS 
  Jesper Mehlsen, Bispebjerg Hospital, Frederiksberg (Denmark)

• Care-seeking in females reporting severe adverse reactions to HPV vaccine: Research and policy perspectives 
  Kåre Mølbak, Statens Serum Institute (Denmark)

• Progress achieved – real world impact from a Danish perspective
  Susanne Krûger Kjaer

• Evidence-based general practice: prevention among healthy people 
  John Brodersen, Centre of Research & Education in General Practice (Denmark)

• Danish Cancer Society initiatives and the background for the initiatives
  Ulla Axelsen, Ringshospitalet and Danish Cancer Society (Denmark)

• Danish Health Authority: possible efforts to increase HPV vaccine uptake
  Bolette Søborg, Danish National Board of Health (Denmark)

Chair and moderator: Margaret Stanley

• Panel discussion.
  Panel: Ulla Axelsen, Susanne Krûger Kjaer, Kåre Mølbak,
  Jesper Mehlsen, Bolette Søborg, John Brodersen

• Conclusions of the day

DAY 2: Friday, November 18th 2016

SESSION 6: GLOBAL ACHIEVEMENTS AND CHALLENGES
Chairs: Emilie Karafillakis & Elsebeth Lynge

• HPV Programs at a global level 
  Ikechukwu Ogbuanu, WHO

• What can we learn from HepB vaccine and other vaccine safety issues?
  Mark Kane, consultant

• Questions & discussion

SESSION 7: THE WAY FORWARD
Chairs: Pierre Van Damme & Camilla Rosengaard Villumsen

• The way forward in Denmark & lessons learnt for the rest of the world: Discussion in working groups

• The way forward in Denmark & lessons learnt for the rest of the world: Plenary: results from the working groups

SESSION 8: CONCLUSIONS OF THE MEETING
Chairs: Silvia de Sanjosé & Bolette Søborg

• Presentation of the meeting conclusions & feedback.
  Marc Baay